N-Desmethyl-N-(allyloxymethyl)-vinblastine and antileukemic and
antilymphomic compositions and method of treatment
    8.
    发明授权
    N-Desmethyl-N-(allyloxymethyl)-vinblastine and antileukemic and antilymphomic compositions and method of treatment 失效
    N-去甲基-N-(烯丙氧基甲基) - 长春花碱和抗白血病和抗病毒组合物和治疗方法

    公开(公告)号:US4490378A

    公开(公告)日:1984-12-25

    申请号:US503791

    申请日:1983-06-13

    CPC分类号: C07D519/04 Y10S514/908

    摘要: The invention relates to new cytostatic compound, process for their preparation and pharmaceutical compositions containing them. More particularly, there are provided new compounds of the general formula ##STR1## in which R.sup.4 is .beta.-hydroxyl andR.sup.3 is .alpha.-ethyl; orR.sup.4 is hydrogen andR.sup.3 is .beta.-ethyl;R" is a straight chained alkyl having from 1 to 10 carbon atoms, or a branched chained alkyl having from 3 to 10 carbon atoms, in which groups the carbon atom attached to the >N.sub.a --CH.sub.2 --O-- group has a primary or secondary configuration or an alkenyl or alkinyl having from 3 to 6 carbon atoms, or an aralkyl having from 1 to 3 carbon atoms in the alkyl moiety;R.sup.1 is methoxy andR.sup.2 is acetyl, provided that if R.sup.3 is .alpha.-ethyl and R.sup.4 .beta.-hydroxyl,R.sup.4 is other than ethyl.These compounds and N-desmethyl-N-(ethoxymethyl)-vinblastine can be prepared according to the invention by transetherification of compounds of the compounds of the general formula ##STR2## with a large excess of alcohols of the general formulaR"--OH [III]Pharmaceutical compositions containing compounds of the general formula [I] as active ingredients are also within the scope of invention.

    摘要翻译: 本发明涉及新的细胞生长抑制化合物,其制备方法和含有它们的药物组合物。 更具体地,提供了通式为“IMAGE”/ I /的新化合物,其中R 4是β-羟基和R 3是α-乙基; 或R4是氢,R3是β-乙基; R“是具有1至10个碳原子的直链烷基或具有3至10个碳原子的支链烷基,其中与> Na-CH 2 -O-基团连接的碳原子具有伯或 二级构型或具有3至6个碳原子的烯基或炔基,或在烷基部分具有1至3个碳原子的芳烷基; R1是甲氧基,R2是乙酰基,条件是如果R3是α-乙基和R4β-羟基,R4不是乙基。 这些化合物和N-去甲基-N-(乙氧基甲基) - 长春花碱可以根据本发明通过将通式为“IMAGE”/ II /的化合物的化合物与大量过量的通式R' '-OH [III]含有通式[I]化合物作为活性成分的药物组合物也在本发明的范围内。

    Process for preparation of cytostatic compounds
    9.
    发明授权
    Process for preparation of cytostatic compounds 失效
    细胞生长抑制化合物的制备方法

    公开(公告)号:US4410459A

    公开(公告)日:1983-10-18

    申请号:US293611

    申请日:1981-08-17

    CPC分类号: C07D519/04 Y10S514/908

    摘要: The invention relates to new cytostatic compound, process for their preparation and pharmaceutical compositions containing them. More particularly, there are provided new compounds of the general formula ##STR1## in which R.sup.4 is .beta.-hydroxyl andR.sup.3 is .alpha.-ethyl; orR.sup.4 is hydrogen andR.sup.3 is .beta.-ethyl;R" is a straight chained alkyl having from 1 to 10 carbon atoms, or a branched chained alkyl having from 3 to 10 carbon atoms, in which groups the carbon atom attached to the >N.sub.a -CH.sub.2 -O-- group has a primary or secondary configuration or an alkenyl or alkinyl having from 3 to 6 carbon atoms, or an aralkyl having from 1 to 3 carbon atoms in the alkyl moiety;R.sup.1 is methoxy andR.sup.2 is acetyl,provided that if R.sup.3 is .alpha.-ethyl and R.sup.4 .beta.-hydroxyl, R.sup.4 is other than ethyl.These compounds and N-desmethyl-N- ethoxy- methyl -vinblastine can be prepared according to the invention by transetherification of compounds of the compounds of the general formula ##STR2## with a large excess of alcohols of the general formulaR"--OH (III)Pharmaceutical compositions containing compounds of the general formula /I/ as active ingredients are also within the scope of invention.

    摘要翻译: 本发明涉及新的细胞生长抑制化合物,其制备方法和含有它们的药物组合物。 更具体地,提供了通式为(I)的新化合物,其中R 4是β-羟基并且R 3是α-乙基; 或R4是氢,R3是β-乙基; R“是具有1至10个碳原子的直链烷基或具有3至10个碳原子的支链烷基,其中与> Na-CH 2 -O-基团连接的碳原子具有伯或 二级构型或具有3至6个碳原子的烯基或炔基,或在烷基部分具有1至3个碳原子的芳烷基; R1是甲氧基,R2是乙酰基,条件是如果R3是α-乙基和R4β-羟基,R4不是乙基。 这些化合物和N-去甲基-N-乙氧基 - 甲基 - 长春花碱可以根据本发明通过将通式为“IMAGE”(II)的化合物的化合物与大量过量的通式R' '-OH(III)含有通式I I化合物作为活性成分的药物组合物也在本发明的范围内。